Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)

Published:2011-03 Issue:3 Volume:161 Page:639-645.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Lagedrost Sarah J.,Sutton Martin St. John,Cohen Meryl S.,Satou Gary M.,Kaufman Beth D.,Perlman Susan L.,Rummey Christian,Meier Thomas,Lynch David R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and interfamilial clustering of clinical features;Harding;Brain,1981

2. Diagnosis and treatment of Friedreich ataxia: a European perspective;Schulz;Nat Rev Neurol,2009

3. Clinical and genetic abnormalities in subjects with Friedreich's ataxia;Dürr;N Engl J Med,1996

4. Frataxin is reduced in Friedreich ataxia subjects and is associated with mitochondrial membranes;Campuzano;Hum Mol Genet,1997

5. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin;Koutnikova;Nat Genet,1997

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Coenzyme Q10 Supplementation in Neonates, Infants and Children: An Overview;Antioxidants;2024-04-26

2. Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data;Expert Opinion on Pharmacotherapy;2024-03-23

3. Emerging antioxidant therapies in Friedreich’s ataxia;Frontiers in Pharmacology;2024-02-06

4. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia;Trends in Molecular Medicine;2024-02

5. Genetic Testing in Cardiomyopathy: Decoding Molecular Underpinnings and Influencing Treatment Decisions;International Journal of Cardiovascular Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3